myeloid

(redirected from myelogenous)
Also found in: Dictionary, Medical.

myeloid

[′mī·ə‚lȯid]
(anatomy)
Of or pertaining to bone marrow.
Of or pertaining to the spinal cord.
References in periodicals archive ?
The Type II Variation application for BOSULIF for adults with newly diagnosed chronic phase Ph+ CML was based on results from BFORE (Bosutinib trial in First line chrOnic myelogenous leukemia tREatment), a randomized multicenter, multinational, open-label, Phase 3, head-to-head study of BOSULIF 400 mg versus imatinib 400 mg, a current standard of care.
About 90 percent of chronic myelogenous leukemia patients treated with imatinib survive for 5 years or longer.
The IOM's subsequent review of the evidence found there is "inadequate or insufficient evidence" to establish a connection between the parent's Agent Orange exposure and development of acute myelogenous leukemia.
The incidence rate of acute myelogenous leukemias (AMLs) in the United States is approximately 2.
M2 PHARMA-May 19, 2015-Agios passes US FDA's fast track designation for AG-120 for treating acute myelogenous leukemia
M2 EQUITYBITES-May 19, 2015-Agios passes US FDA's fast track designation for AG-120 for treating acute myelogenous leukemia
The medicine known commercially as Gleevec serves as a powerful weapon for people fighting the blood cancer called chronic myelogenous leukemia, or CML.
M2 EQUITYBITES-December 9, 2014-AbbVie reveals results from Phase 2 study of venetoclax in patients with acute myelogenous leukaemia
M2 PHARMA-December 9, 2014-AbbVie reveals results from Phase 2 study of venetoclax in patients with acute myelogenous leukaemia